APA (7th ed.) Citation

Boglione, L., Pinna, S., Cardellino, C., Nicolò, A., Cusato, J., Carcieri, C., . . . D'Avolio, A. (2017). Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors. Infection, 45(1), 103. https://doi.org/10.1007/s15010-016-0962-3

Chicago Style (17th ed.) Citation

Boglione, Lucio, Simone Pinna, Chiara Cardellino, Amedeo Nicolò, Jessica Cusato, Chiara Carcieri, Giuseppe Cariti, Giovanni Perri, and Antonio D'Avolio. "Treatment with Daclatasvir and Sofosbuvir for 24 Weeks Without Ribavirin in Cirrhotic Patients Who Failed First-generation Protease Inhibitors." Infection 45, no. 1 (2017): 103. https://doi.org/10.1007/s15010-016-0962-3.

MLA (9th ed.) Citation

Boglione, Lucio, et al. "Treatment with Daclatasvir and Sofosbuvir for 24 Weeks Without Ribavirin in Cirrhotic Patients Who Failed First-generation Protease Inhibitors." Infection, vol. 45, no. 1, 2017, p. 103, https://doi.org/10.1007/s15010-016-0962-3.